Learn, Analyse & Invest
only with
only with
+91
Download Orca
Bijoy Hans Ltd.
Bijoy Hans
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹2.65 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results |
| 08 11 2021 | Quarterly Results |
| 08 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 03 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 01 02 2023 | Quarterly Results & Inter alia, to consider Appointment of Secretarial Auditor of the Company for the financial year 2022-23. |
| 30 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 14 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 12 03 2024 | Inter alia, to consider and approve the application for Revocation of Suspension of Securities before the Calcutta Stock Exchange Limited |
| 08 10 2024 | Inter alia, to consider and approve the resignation of Mr. Raj Kumar Harlalka (DIN: 00594512) as Independent Director of the Company |
| 09 11 2024 | Quarterly Results |
| 26 12 2024 | Preferential Issue of shares & Increase in Authorised Capital |
| 07 01 2025 | Interalia to consider and approve :- i. To consider and approve the notice and calendar of events for Postal Ballot. ii. To consider the Appointment of Scrutinizer to conduct a Postal Ballot process. iii. Any other business with the permission of the chair. |
| 04 02 2025 | Quarterly Results |
| 28 03 2025 | Independent Director Meeting |
| 26 05 2025 | Audited Results & Dividend |
| 28 07 2025 | Quarterly Results Inter alia, to consider and approve:- 1. Pursuant to Successful completion of open offer, there will be a change in the control & management of the Company. Hence there will be change in composition of the Board of Directors of the Company. 2. The Unaudited Standalone Financial Results of the company for the quarter ended on 30th June, 2025 along with the Limited review report. 3. Appointment of New Additional Director(s) of the Company. 4. To re-constitute the various committees. 5. To re-designate the designation of Mr. Kaushal Uttam shah as Managing Director and Chairman of the Company subject to approval of the shareholder in their meeting. 6. Any other matter with the permission of the chair. |
| 26 09 2025 | Voluntary Delisting of Shares |
| 04 11 2025 | Quarterly Results & Increase in Authorised Capital Inter alia, to consider and approve:- 1. Consider and evaluate proposal for raising of funds by the Company, by way of issuance of Equity Shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alia, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, pursuant to the provisions of the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and subject to other applicable rules, regulations and guidelines of Securities and Exchange Board of India. 2. To consider and approve increase in Authorised Share Capital of the Company and consequential alteration in the Memorandum of Association. 3. To consider & approve the standalone unaudited financial results as recommended by the audit committee for the second quarter and half year ended 30th September, 2025 along with the limited review report. |
| 13 02 2026 | Quarterly Results |
| 04 03 2026 | Inter alia, to consider and approve :- 1. To consider and approve the request received as per our earlier intimation dated 24th February, 2026 from Mr. Ashok Patwari, Mr. Ashim Patwari, Mrs. Sushila Devi Patwari & Ms. Shweta Patwari, who are presently classified as part of Promoter and Promoter Group of the Company for reclassification to public category. 2. Any other matter with the permission of the Chair |
| 11 03 2026 | Inter-alia, 1. To consider and approve the proposal for withdrawal of the new name of the Company i.e. Arvaya Healthtech Limited that was earlier approved by the Ministry of Corporate Affairsthrough RUN Application vide its SRN AC1508469 and subsequently by the members in the Extraordinary General Meeting (EGM) held on 25th February, 2026 in view of the revised strategic business decisions of the management, and to authorize the Board of Directors to take necessary actions and make requisite filings with the concerned authorities to give effect to the same. 2. The Board will consider the proposal to change the existing name of the Company from Bijoy Hans Limited to Arvaya Healthcare Limited or Arvaya Healthcare and Wellness Limited , subject to the approval of the Registrar of Companies and other applicable authorities, in accordance with the provisions of the Companies Act, 2013 and the rules made thereunder. The proposed change of name is intended to better reflect the Company s evolving business activities, vision, and long-term objectives. In this regard, the Board will also consider making an application for reservation of the proposed name through the RUN (Reserve Unique Name) service with the Ministry of Corporate Affairs. 3. Any other matter with the permission of the Chair. |
| 17 03 2026 | Increase in Authorised Capital |
News
